Psychiatry and Neurology, Neurology · Wichita Falls, TX
NPI
1679535843
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
1722 9th St
Wichita Falls, TX, 76301
Phone (940) 322-1075
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.2M
136,510 services
Medicare patients, 2024
987
Average age 70
Drug cost, 2024
$7.4M
14,670 prescriptions
Company payments, 2025
$5,119
From 42 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Danny R Bartel was code J2323 (injection, natalizumab, 1 mg), 30,000 times for 12 patients. In total Danny R Bartel billed 136,510 services in 96 codes, and Medicare paid $5.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2323 Injection, natalizumab, 1 mg | Office | 30,000 | 12 | $18.98 | $569K |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 24,335 | 688 | $49.31 | $1.2M |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 12,545 | 17 | $38.72 | $486K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 7,450 | 25 | $0.22 | $1,631 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 5,146 | 697 | $87.85 | $452K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,441 | 39 | $0.10 | $246 |
| 99214 Office E&M - Established | Office | 1,801 | 797 | $95.45 | $172K |
| 95886 Electrical Nerve Conductivity | Office | 1,693 | 410 | $77.74 | $132K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 848 | 23 | $0.09 | $75.65 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 431 | 22 | $0.07 | $30.88 |
| 96375 Injection Administration | Office | 428 | 49 | $11.24 | $4,810 |
| 95913 Electrical Nerve Conductivity | Office | 419 | 404 | $229.02 | $96K |
| 96366 Intravenous Infusion, Hydration | Office | 413 | 25 | $14.95 | $6,176 |
| 95813 Neurologic | Office | 334 | 312 | $351.78 | $117K |
| 96365 Intravenous Infusion, Hydration | Office | 331 | 51 | $45.62 | $15K |
By year: 2022 $4.9M for 96,090 services; 2023 $6.3M for 147,236 services; 2024 $5.2M for 136,510 services.
Medicare prescription drug claims, 2024
In 2024, the drug Danny R Bartel prescribed most often to Medicare patients was Levetiracetam, with 935 prescriptions and refills. In total Danny R Bartel wrote 14,670 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 935 | 1,753 | 214 | $22K |
| Gabapentin Generic | 676 | 1,026 | 140 | $12K |
| Hydroxychloroquine Sulfate Generic | 506 | 752 | 121 | $14K |
| Meloxicam Generic | 488 | 832 | 127 | $2,173 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 410 | 605 | 62 | $6,924 |
| Dexamethasone Generic | 394 | 416 | 131 | $2,709 |
| Clopidogrel Clopidogrel Bisulfate | 384 | 775 | 102 | $3,505 |
| Oxcarbazepine Generic | 380 | 610 | 72 | $19K |
| Pregabalin Generic | 299 | 388 | 66 | $8,974 |
| Tizanidine Hcl Generic | 295 | 349 | 65 | $3,884 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 244 | 244 | 39 | $7,757 |
| Amitriptyline Hcl Generic | 234 | 439 | 55 | $5,024 |
| Meclizine Hcl Generic | 224 | 391 | 60 | $2,751 |
| Topiramate Generic | 217 | 373 | 54 | $2,145 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 191 | 191 | 65 | $4,722 |
Brand drugs: 1,397 claims; generic drugs: 13,252 claims; opioid claims: 620.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Danny R Bartel $5,119 ($5,119 in general payments such as food, travel and fees) from 42 companies. The largest payer was UCB, Inc. with $488.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 25 | $488 |
| Biogen, Inc. BIIB | 20 | $398 |
| Neurocrine BioSciences, Inc. NBIX | 18 | $336 |
| LivaNova USA, Inc. LIVN | 4 | $304 |
| Pfizer Inc. PFE | 20 | $265 |
| ANI Pharmaceuticals, Inc. ANIP | 16 | $221 |
| SK Life Science, Inc. | 11 | $217 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $199 |
| Abbvie Inc. ABBV | 17 | $198 |
| Amgen Inc. AMGN | 13 | $193 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.